- Home
- PEBK vs ALEC Comparison
PEBK vs ALEC Comparison
Compare PEBK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBK | ALEC |
|---|---|---|
| Founded | 1912 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.0M | 133.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PEBK | ALEC |
|---|---|---|
| Price | $36.10 | $1.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 11.2K | ★ 1.6M |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 3.06 | N/A |
| Revenue | ★ $85,500,000.00 | $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $155.87 |
| P/E Ratio | $11.83 | ★ N/A |
| Revenue Growth | 6.88 | ★ 12.26 |
| 52 Week Low | $23.74 | $0.87 |
| 52 Week High | $38.46 | $3.40 |
Technical Indicators
Market Signals| Indicator | PEBK | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 57.46 | 56.66 |
| Support Level | $36.15 | $1.40 |
| Resistance Level | $38.40 | $1.49 |
| Average True Range (ATR) | 0.79 | 0.09 |
| MACD | -0.32 | 0.03 |
| Stochastic Oscillator | 10.61 | 67.72 |
Price Performance
Historical ComparisonAbout PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.